Supportive Oligonucleotide Therapy (SOT)

SOT is a personalized therapy for cancer, viruses and pathogens, including Lyme disease.

SOT has the ability to bind to a specific gene of interest that controls the cancer cell or pathogen by disrupting the critical process that promotes its survival or growth.

During this therapy, a patient's blood is analyzed and a complementary oligonucleotide sequence is created that is designed to disrupt cell survival or growth. SOT from RGCC Laboratories.